|
2025-05-13 |
2025-05-09 |
S
Sale
|
Hickey Benjamin
President, RayzeBio Org.
Officer
|
97
-100.0%
38.01
USD 3,702
|
97
-100.0%
|
38.01
|
USD 3,702
|
|
|
2025-04-29 |
2025-04-25 |
B
Purchase
|
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
Officer
|
4,250
+5.4%
47.58
USD 202,215
|
4,250
+5.4%
|
47.58
|
USD 202,215
|
|
|
2025-02-21 |
2025-02-20 |
B
Purchase
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
Executive Director
|
2,000
+1.9%
55.05
USD 110,096
|
2,000
+1.9%
|
55.05
|
USD 110,096
|
|
|
2025-02-19 |
2025-02-14 |
B
Purchase
|
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
Officer
|
1,823
+2.9%
54.84
USD 100,000
|
1,823
+2.9%
|
54.84
|
USD 100,000
|
|
|
2024-11-05 |
2024-11-04 |
S
Sale
|
Holzer Phil M
SVP and Controller
Officer
|
700
-5.6%
55.62
USD 38,931
|
700
-5.6%
|
55.62
|
USD 38,931
|
|
|
2024-11-05 |
2024-11-01 |
B
Purchase
|
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
Officer
|
1,830
+3.0%
54.68
USD 100,055
|
1,830
+3.0%
|
54.68
|
USD 100,055
|
|
|
2023-12-07 |
2023-12-05 |
B
Purchase
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
Officer
|
2,000
+2.5%
49.78
USD 99,560
|
2,000
+2.5%
|
49.78
|
USD 99,560
|
|
|
2023-11-30 |
2023-11-28 |
B
Purchase
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
Officer
|
3,071
+4.0%
48.86
USD 150,049
|
3,071
+4.0%
|
48.86
|
USD 150,049
|
|
|
2023-11-21 |
2023-11-20 |
B
Purchase
|
Samuels Theodore R. II
Non-Executive Director
|
8,500
+31.5%
49.81
USD 423,385
|
8,500
+31.5%
|
49.81
|
USD 423,385
|
|
|
2023-08-28 |
2023-08-24 |
S
Sale
|
Powell Ann
EVP, Chief Human Resources
Officer
|
17,986
-39.2%
61.25
USD 1,101,643
|
17,986
-39.2%
|
61.25
|
USD 1,101,643
|
|
|
2023-08-07 |
2023-08-03 |
S
Sale
|
Plenge Robert M
EVP, Chief Research Officer
Officer
|
732
-10.0%
61.14
USD 44,754
|
732
-10.0%
|
61.14
|
USD 44,754
|
|
|
2023-05-04 |
2023-05-03 |
S
Sale
|
VESSEY RUPERT
EVP & President, Research
Officer
|
50,385
-51.3%
67.06
USD 3,378,818
|
50,385
-51.3%
|
67.06
|
USD 3,378,818
|
|
|
2023-02-08 |
2023-02-06 |
S
Sale
|
Powell Ann
EVP, Chief Human Resources
Officer
|
11,183
-32.7%
74.69
USD 835,258
|
11,183
-32.7%
|
74.69
|
USD 835,258
|
|
|
2023-02-08 |
2023-02-06 |
S
Sale
|
Caforio Giovanni
Board Chair and CEO
Executive Director
|
240,000
-50.4%
74.65
USD 17,916,000
|
240,000
-50.4%
|
74.65
|
USD 17,916,000
|
|
|
2022-11-14 |
2022-11-09 |
S
Sale
|
Powell Ann
EVP, Chief Human Resources
Officer
|
16,250
-32.2%
80.45
USD 1,307,313
|
16,250
-32.2%
|
80.45
|
USD 1,307,313
|
|
|
2022-11-09 |
2022-11-07 |
S
Sale
|
VESSEY RUPERT
EVP, Research & Early Dev.
Officer
|
45,910
-44.6%
78.88
USD 3,621,381
|
45,910
-44.6%
|
78.88
|
USD 3,621,381
|
|
|
2022-09-22 |
2022-09-20 |
PS
Planned sale
|
Caforio Giovanni
Board Chair and CEO
Executive Director
|
25,000
-5.0%
69.71
USD 1,742,750
|
25,000
-5.0%
|
69.71
|
USD 1,742,750
|
|
|
2022-09-16 |
2022-09-15 |
S
Sale
|
Caforio Giovanni
Board Chair and CEO
Executive Director
|
50,000
-9.1%
71.84
USD 3,592,000
|
50,000
-9.1%
|
71.84
|
USD 3,592,000
|
|
|
2022-09-15 |
2022-09-14 |
S
Sale
|
Powell Ann
EVP, Chief Human Resources
Officer
|
25,000
-33.1%
70.75
USD 1,768,750
|
25,000
-33.1%
|
70.75
|
USD 1,768,750
|
|
|
2022-09-15 |
2022-09-13 |
S
Sale
|
Elkins David V
EVP, Chief Financial Officer
Officer
|
103,951
-46.5%
71.29
USD 7,410,667
|
103,951
-46.5%
|
71.29
|
USD 7,410,667
|
|
